PetMed Express, Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 30,000 shares of the stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $51.00, for a total transaction of $1,530,000.00. Following the completion of the sale, the chief executive officer now owns 490,000 shares in the company, valued at $24,990,000. The transaction was disclosed in a filing with the SEC, which is available through this link.
PetMed Express, Inc. (NASDAQ:PETS) opened at $50.88 on Thursday. The company has a market cap of $1,050.00, a price-to-earnings ratio of 34.15, a PEG ratio of 3.14 and a beta of 1.12. PetMed Express, Inc. has a twelve month low of $19.21 and a twelve month high of $53.90.
PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, October 23rd. The company reported $0.43 EPS for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.13. The firm had revenue of $66.70 million for the quarter, compared to analyst estimates of $63.41 million. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.24 EPS. equities analysts anticipate that PetMed Express, Inc. will post 1.68 earnings per share for the current year.
Several large investors have recently modified their holdings of PETS. Acrospire Investment Management LLC bought a new position in shares of PetMed Express during the 2nd quarter valued at $110,000. Pinebridge Investments L.P. grew its holdings in shares of PetMed Express by 1.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock valued at $110,000 after purchasing an additional 27 shares during the last quarter. Sei Investments Co. grew its holdings in shares of PetMed Express by 50,142.9% during the 3rd quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock valued at $117,000 after purchasing an additional 3,510 shares during the last quarter. Thompson Siegel & Walmsley LLC bought a new position in shares of PetMed Express during the 3rd quarter valued at $149,000. Finally, Fred Alger Management Inc. bought a new position in shares of PetMed Express during the 2nd quarter valued at $162,000. 99.88% of the stock is currently owned by hedge funds and other institutional investors.
Several research firms have issued reports on PETS. Credit Suisse Group reiterated an “underperform” rating and issued a $19.00 target price on shares of PetMed Express in a research note on Monday, October 2nd. ValuEngine cut shares of PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Zacks Investment Research cut shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. Northcoast Research set a $58.00 target price on shares of PetMed Express and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. Finally, BidaskClub upgraded shares of PetMed Express from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 9th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and one has given a strong buy rating to the company. PetMed Express has an average rating of “Hold” and an average price target of $42.80.
ILLEGAL ACTIVITY NOTICE: This story was first reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://ledgergazette.com/2018/01/18/menderes-akdag-sells-30000-shares-of-petmed-express-inc-pets-stock.html.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.